Published in Am J Health Syst Pharm on December 01, 1996
Restructuring and patient-focused care. Am J Health Syst Pharm (1995) 3.94
Cytoskeletal reorganization underlying growth cone motility. Curr Opin Neurobiol (1994) 1.67
Regulation of pH by the M2 protein of influenza A viruses. Virus Res (1992) 1.63
Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol (2013) 1.41
Screening the smoking issue. Am J Hosp Pharm (1994) 1.39
Dispensing fees threatened by Medicaid cuts. Am J Health Syst Pharm (1995) 1.39
Feasibility of using administrative data to compare hospital performance in the EU. Int J Qual Health Care (2014) 1.25
The use of on-site visits to assess compliance and implementation of quality management at hospital level. Int J Qual Health Care (2014) 1.11
Prescription drug misuse highlighted as national problem. Am J Health Syst Pharm (2001) 1.11
Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate (2000) 1.10
Delayed lactogenesis in women with insulin-dependent diabetes mellitus. Am J Clin Nutr (1993) 1.04
Analysis of anterior pituitary hormone mRNA expression in immunophenotypically characterized single cells after laser capture microdissection. Lab Invest (1999) 1.00
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Leukemia (2010) 0.96
Comparison of AIN-76A and AIN-93G diets: a 13-week study in rats. Food Chem Toxicol (2001) 0.89
Impairment of carotid-cardiac vagal baroreflex in wheelchair-dependent quadriplegics. Am J Physiol (1991) 0.88
Enhanced inhibition of mammary carcinogenesis by combined treatment with N-(4-hydroxyphenyl)retinamide and ovariectomy. Cancer Res (1982) 0.84
Development and validation of an index to assess hospital quality management systems. Int J Qual Health Care (2014) 0.84
The toxicity and neuropathology of dimethylethyltin and methyldiethyltin in rats. Neuropathol Appl Neurobiol (1987) 0.81
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma. Blood Cancer J (2013) 0.80
Alosetron withdrawn from market. Am J Health Syst Pharm (2001) 0.80
Diminished baroreflex control of forearm vascular resistance following training. Med Sci Sports Exerc (1991) 0.80
Physician leaders hear details on pharmacist collaborative drug therapy management. Am J Health Syst Pharm (2001) 0.80
Diffusive media characterization with laser speckle. Appl Opt (1997) 0.79
FDA admits to lacking control over counterfeit drug imports. Am J Health Syst Pharm (2000) 0.79
Haemodynamic and ADH responses to central blood volume shifts in cardiac-denervated humans. Clin Physiol (1990) 0.78
Lung function and airway cytologic profiles in horses with recurrent airway obstruction maintained in low-dust environments. J Vet Intern Med (2007) 0.78
Raman spectroscopic studies of diamond in Intralipid. Opt Lett (1995) 0.78
Cerivastatin withdrawn from market. Am J Health Syst Pharm (2001) 0.77
Successful treatment with thalidomide of a patient with congenital factor V deficiency and factor V inhibitor with recurrent gastrointestinal bleeding from small bowel arteriovenous malformations. Haemophilia (2012) 0.77
As patients embrace herbal remedies, dearth of scientific evidence frustrates clinicians. Am J Health Syst Pharm (1997) 0.77
FDA approves galantamine for Alzheimer's disease. Am J Health Syst Pharm (2001) 0.77
Inhibition by retinoid and ovariectomy of additional primary malignancies in rats following surgical removal of the first mammary cancer. Cancer (1983) 0.77
USP moves forward in providing information on botanical products. Am J Health Syst Pharm (1998) 0.77
Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies. Adv Ther (2000) 0.76
In vitro correlation of ultrastructural morphology and creatine phosphokinase release in L6 skeletal muscle cells after exposure to parenteral antibiotics. In Vitro Cell Dev Biol (1990) 0.76
Frequency domain modeling of reradiation in highly scattering media. Appl Opt (1997) 0.76
Baroreflex responses and LBNP tolerance following exercise training. Physiologist (1990) 0.75
Federal-discount prices still off-limits to public hospitals. Am J Health Syst Pharm (1995) 0.75
New interferon alfa formulation licensed for treatment of hepatitis C. Am J Health Syst Pharm (2001) 0.75
Companies try different plans for same clotting factor product. Am J Health Syst Pharm (2001) 0.75
HHS clarifies privacy rule. Am J Health Syst Pharm (2001) 0.75
Card-carrying HMO members test health record technology. Am J Hosp Pharm (1994) 0.75
Communicating medication risk. Am J Health Syst Pharm (1995) 0.75
Unit-of-use packaging to remain optional for now. Am J Hosp Pharm (1993) 0.75
Effect of mono-(2-ethylhexyl) phthalate on the metabolism of energy-yielding substrates in rat sertoli cell-enriched cultures. Toxicol In Vitro (1989) 0.75
Omeprazole isomer approved by FDA. Am J Health Syst Pharm (2001) 0.75
Antiretroviral combination may put pregnant women at risk of fatal lactic acidosis. Am J Health Syst Pharm (2001) 0.75
Test of USP program for testing dietary supplements gets under way. Am J Health Syst Pharm (2001) 0.75
Health care system needs overhaul, IOM report says. Am J Health Syst Pharm (2001) 0.75
Long-acting asthma medication, new inhaler approved by FDA. Am J Health Syst Pharm (2001) 0.75
Herbal quality seems to be growing. Am J Health Syst Pharm (1998) 0.75
Biointerventional cardiovascular therapy. Eur Heart J (2002) 0.75
Federal drug discount program proves tricky for hospitals to navigate. Am J Health Syst Pharm (2000) 0.75
International pharmacists group convenes in Singapore. Am J Health Syst Pharm (2001) 0.75
Medical devices with latex become easier to identify. Am J Health Syst Pharm (1998) 0.75
Serious surveillance. Am J Health Syst Pharm (1999) 0.75
Movement to temperature monitoring loses steam. Am J Health Syst Pharm (1999) 0.75
An intercultural comparison of immediacy among Japanese and Americans. Percept Mot Skills (1990) 0.75
Exaggerated response to gentamicin-induced nephrotoxicity in Sprague-Dawley rats: identification of a highly sensitive outlier population. Toxicol Pathol (1986) 0.75
Radiopharmaceutical providers to continue growth. Am J Hosp Pharm (1993) 0.75
Pharmaceuticals hit the internet auction block. Am J Health Syst Pharm (2000) 0.75
Scientific and trade groups clash over 'authoritative' statements for health claims. Am J Health Syst Pharm (1999) 0.75
Better care needed for Medicare patients, says HCFA. Collaboration will be key to success. Am J Health Syst Pharm (2000) 0.75
Temporal association between arterial cholesterol deposition, thymidine incorporation into DNA, and atherosclerosis in Japanese quail fed an atherogenic diet. Atherosclerosis (1982) 0.75
Work and pregnancy: individual and organizational factors influencing organizational commitment, timing of maternity leave, and return to work. Sex Roles (1999) 0.75
Safe handling of cyclophosphamide. Am J Hosp Pharm (1990) 0.75
Once-weekly erythropoiesis-stimulating protein enters market. Am J Health Syst Pharm (2001) 0.75
Hospitalists offer prospect for increased efficiencies. Am J Health Syst Pharm (1999) 0.75
Triple-drug tablet approved for HIV infection. Am J Health Syst Pharm (2001) 0.75
CDC advises delaying tetanus booster shots for adults, adolescents until 2002. Am J Health Syst Pharm (2001) 0.75
Using cytotoxic drugs safely. Nursing (1994) 0.75
Conference explores patient-focused computing. Am J Hosp Pharm (1994) 0.75
Monoclonal antibody licensed for third-line treatment of B-cell chronic lymphocytic leukemia. Am J Health Syst Pharm (2001) 0.75
Oral budesonide approved for active Crohn's disease. Am J Health Syst Pharm (2001) 0.75
Privacy regulations go into effect, with modifications to come later. Am J Health Syst Pharm (2001) 0.75
FDA approves digoxin-toxicity remedy. Am J Health Syst Pharm (2001) 0.75
Withdrawn drugs posed greater health risk for women than men, GAO says. Am J Health Syst Pharm (2001) 0.75
Managed care undervalues beneficial nonprescription drugs. Am J Health Syst Pharm (2000) 0.75
The toxicity and neuropathology of 2,4,5-tribromoimidazole and its derivatives in rats. Arch Toxicol (1984) 0.75
Finnish and American university students compared on a verbal aggression construct. Psychol Rep (1991) 0.75
HHS accuses infusion companies of overcharging. Am J Health Syst Pharm (2000) 0.75
USP issues first report from medication-errors database. Am J Health Syst Pharm (2001) 0.75
Alteplase licensed for catheter clearance. Am J Health Syst Pharm (2001) 0.75
Sending material for publication in AJHP via Internet. Am J Health Syst Pharm (1995) 0.75
New type of antifungal approved for invasive aspergillosis. Am J Health Syst Pharm (2001) 0.75
Journals, FDA announce steps to encourage ADR reporting. Am J Hosp Pharm (1994) 0.75
Opinions on useful patient drug information aired at FDA workshop. Opposition to MedGuide proposal runs strong. Am J Health Syst Pharm (1996) 0.75
Infliximab licensing expands to include halting arthritis progression. Am J Health Syst Pharm (2001) 0.75
Oral prodrug enters cephalosporin market. Am J Health Syst Pharm (2001) 0.75
CDC advises delay in pneumococcal immunization of certain children. Am J Health Syst Pharm (2001) 0.75
Health illiteracy interferes with care. Am J Health Syst Pharm (2001) 0.75
HCFA finalizes rule on Medicare coverage of outpatient diabetes self-management training. Am J Health Syst Pharm (2001) 0.75
AHRQ assesses evidence for best management of COPD exacerbations. Am J Health Syst Pharm (2001) 0.75
Unconventional medicine. Am J Hosp Pharm (1993) 0.75
Internet-based prescribing and dispensing trouble medical and pharmacy boards. Am J Health Syst Pharm (1999) 0.75
Bizarre big belly ball: intraabdominal abscess mimicking stauffer syndrome secondary to uterine leiomyosarcoma. Eur J Gynaecol Oncol (2007) 0.75
Reconciling uncertain costs and benefits in Bayes nets for invasive species management. Risk Anal (2009) 0.75
Submitting reports of adverse drug reactions to AJHP. Am J Hosp Pharm (1994) 0.75
Genome holds key to preventive medicine. Am J Health Syst Pharm (2001) 0.75